Human Leukocyte-Associated Immunoglobulin-Like Receptor 2 (LAIR2) Protein

Este producto es parte de LAIR2 - leukocyte associated immunoglobulin like receptor 2
Product Graph
312€ (20 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Leukocyte-Associated Immunoglobulin-Like Receptor 2 (LAIR2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx694106
tested applications
SDS-PAGE

Description

Human Leukocyte-Associated Immunoglobulin-Like Receptor 2 (LAIR2) Protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

CategoryProteins and Peptides
HostHEK293 cells
OriginHuman
Observed MWMolecular Weight: Calculated MW: 15.1 kDa Observed MW (SDS-PAGE): 19 kDa Sequence Fragment: Gln22-Pro152 Tag: C-terminal His tag
ExpressionRecombinant
Purity>95% (SDS-PAGE)
Purification0.2 μm filtered prior to lyophilization.
Size 120 µg
Size 2100 µg
FormLyophilized Reconstitute in sterile H2O. Do not vortex.
Tested ApplicationsSDS-PAGE
BufferPrior to lyophilization: 20 mM PB, 150 mM NaCl, pH 7.4, containing 5% - 8% Trehalose, Mannitol and 0.01% Tween-80.
AvailabilityShipped within 5-15 working days.
StorageStore lyophilized between -20 °C and -80 °C.
Dry IceNo
UniProt IDQ6ISS4
Gene ID394
OMIM62993
AliasLeukocyte-associated immunoglobulin-like receptor 2,CD306,LAIR-2
BackgroundProtein LAIR2
StatusRUO
NoteThis product is for research use only. Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Leukocyte Associated Immunoglobulin-Like Receptor 2 (LAIR2) is a soluble immunoregulatory protein belonging to the immunoglobulin superfamily. LAIR2 functions primarily as a natural inhibitor of immune activation by competing with its membrane-bound counterpart, LAIR1, for binding to collagens present in the extracellular matrix. This competitive binding prevents LAIR1-mediated inhibitory signaling on immune cells such as T cells, natural killer (NK) cells, and dendritic cells, which are crucial for maintaining immune homeostasis and preventing excessive immune activation. LAIR2 is expressed predominantly in immune-related tissues, including the spleen, bone marrow, and lymph nodes, and its soluble nature allows it to circulate freely in the bloodstream, acting as a systemic modulator of collagen-induced immunosuppression. Dysregulated LAIR2 expression has been implicated in various pathological conditions, such as autoimmune diseases, where its elevated levels may counteract excessive immune inhibition, or in cancers, where it could interfere with tumor-induced immunosuppressive microenvironments. Therapeutically, LAIR2 has shown promise as a biomarker for immune dysregulation and as a potential agent in immunotherapy strategies aimed at mitigating immune suppression in cancers or promoting immune tolerance in autoimmune disorders. Its precise role and interactions with other immune checkpoints continue to be a subject of active research, with a focus on leveraging its properties for clinical applications in immune modulation.

Related Products

abx067774

Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Protein

Recombinant Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) is a recombinant Human protein produced in a Prokaryotic expression system (E. coli).

Ver Producto
abx104584

Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) Antibody

Polyclonal Antibody to Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2).

Ver Producto
abx152154

Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) ELISA Kit

Human Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2) ELISA Kit is an ELISA Kit for the in vitro quantitative measurement of Human LAIR2 concentrations in serum, plasma, urine and other biological fluids. This assay has high sensitivity and excellent specificity for detection of Leukocyte Associated Immunoglobulin Like Receptor 2 (LAIR2)

Ver Producto